• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者自发性肿瘤破裂的肝部分切除术:一项回顾性队列研究

Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study.

作者信息

Zhu Qian, Qiao Guo-Liang, Xu Chang, Guo De-Liang, Tang Jie, Duan Rui, Li Yun

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Jingmen First People's Hospital, Jingmen, Hubei Province.

Department of Medical Oncology, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Beijing.

出版信息

Cancer Manag Res. 2017 Oct 19;9:525-537. doi: 10.2147/CMAR.S146708. eCollection 2017.

DOI:10.2147/CMAR.S146708
PMID:29089785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5655153/
Abstract

BACKGROUND

The impact of ruptured hepatocellular carcinoma (HCC) on a patients outcome after hepatic resection remains insufficient. We aimed to identify the independent predictive factors of spontaneous tumor rupture (STR) for curative resection of HCC and to investigate the impact of STR of HCC on long-term survival after resection.

PATIENTS AND METHODS

The clinicopathological parameters of 106 patients with ruptured HCC and 201 patients with non-ruptured HCC who underwent hepatic resection from 2007 to 2011 were investigated. Clinical features and factors associated with the clinical outcomes were compared between both groups.

RESULTS

Of 774 HCC patients who underwent surgical resection, 106 (13.7%) had tumor rupture. Multivariate stepwise logistic regression analysis revealed hypertension, liver cirrhosis, total bilirubin (TB), tumor size and ascites to be independent prognostic factors for patients with ruptured HCC. The overall survival (OS) of patients in the ruptured HCC group was significantly poorer compared with those in the non-ruptured HCC group. The 1-, 3- and 5-year OS rates were 77.7%, 56.9% and 41.6%, respectively, in the non-ruptured HCC group and 37.7%, 19.7%, 14.%, respectively, in the ruptured HCC group (<0.001). Similar OS rates were found in patients with non-ruptured and ruptured HCC; patients in the non-ruptured HCC group had a significantly better recurrence-free survival (RFS) rate compared with those in the ruptured group (=0.016).

CONCLUSION

The presence of hypertension, liver cirrhosis, higher TB levels, tumor size >5 cm and ascites are the independent indicators of poorer prognosis for patients undergoing hepatic resection after ruptured HCC. The present study confirmed that tumor rupture itself had a negative impact on patient survival, but hepatic resection, when technically feasible, is safe and appropriate in selected patients and can result in OS and RFS rates comparable to that of patients with non-ruptured HCC.

摘要

背景

肝细胞癌(HCC)破裂对肝切除术后患者预后的影响尚不明确。我们旨在确定HCC根治性切除术中自发性肿瘤破裂(STR)的独立预测因素,并研究HCC的STR对切除术后长期生存的影响。

患者与方法

对2007年至2011年接受肝切除的106例破裂HCC患者和201例未破裂HCC患者的临床病理参数进行研究。比较两组的临床特征及与临床结局相关的因素。

结果

在774例行手术切除的HCC患者中,106例(13.7%)发生肿瘤破裂。多因素逐步逻辑回归分析显示,高血压、肝硬化、总胆红素(TB)、肿瘤大小和腹水是破裂HCC患者的独立预后因素。与未破裂HCC组相比,破裂HCC组患者的总生存期(OS)明显较差。未破裂HCC组的1年、3年和5年OS率分别为77.7%、56.9%和41.6%,而破裂HCC组分别为37.7%、19.7%、14%(P<0.001)。未破裂和破裂HCC患者的OS率相似;未破裂HCC组患者的无复发生存期(RFS)率明显高于破裂组(P=0.016)。

结论

高血压、肝硬化、TB水平升高、肿瘤大小>5 cm和腹水的存在是破裂HCC肝切除术后患者预后较差的独立指标。本研究证实肿瘤破裂本身对患者生存有负面影响,但在技术可行的情况下,肝切除对部分患者是安全且合适的,其OS和RFS率与未破裂HCC患者相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/5655153/d4f7633a4fb1/cmar-9-525Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/5655153/4810518dbdbe/cmar-9-525Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/5655153/d4f7633a4fb1/cmar-9-525Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/5655153/4810518dbdbe/cmar-9-525Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b02d/5655153/d4f7633a4fb1/cmar-9-525Fig2.jpg

相似文献

1
Partial hepatectomy for spontaneous tumor rupture in patients with hepatocellular carcinoma: a retrospective cohort study.肝细胞癌患者自发性肿瘤破裂的肝部分切除术:一项回顾性队列研究
Cancer Manag Res. 2017 Oct 19;9:525-537. doi: 10.2147/CMAR.S146708. eCollection 2017.
2
Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.肝细胞癌自发破裂的预测因素和临床结局。
World J Gastroenterol. 2012 Dec 28;18(48):7302-7. doi: 10.3748/wjg.v18.i48.7302.
3
Predictors of Spontaneous Rupture of Hepatocellular Carcinoma and Clinical Outcomes Following Hepatectomy.肝细胞癌自发性破裂的预测因素及肝切除术后的临床结局
Front Oncol. 2022 Jan 27;12:820867. doi: 10.3389/fonc.2022.820867. eCollection 2022.
4
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.微血管侵犯和乙肝e抗原阳性与早期肝细胞癌肝切除术后较差的生存率相关:一项回顾性队列研究。
Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):330-338. doi: 10.1016/j.clinre.2018.02.003. Epub 2018 Mar 16.
5
Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy.肝细胞癌自发破裂:肝部分切除术的最佳时机。
Eur J Surg Oncol. 2019 Oct;45(10):1887-1894. doi: 10.1016/j.ejso.2019.02.033. Epub 2019 Mar 5.
6
Partial hepatectomy for ruptured hepatocellular carcinoma.部分肝切除术治疗破裂的肝细胞癌。
Br J Surg. 2013 Jul;100(8):1071-9. doi: 10.1002/bjs.9167.
7
An Analysis of Surgical Treatment for the Spontaneous Rupture of Hepatocellular Carcinoma.肝细胞癌自发性破裂的外科治疗分析
Dig Surg. 2016;33(1):43-50. doi: 10.1159/000441531. Epub 2015 Nov 19.
8
Prognostic influence of spontaneous tumor rupture on hepatocellular carcinoma after interval hepatectomy.间隔肝切除术后自发性肿瘤破裂对肝细胞癌的预后影响
Surgery. 2016 Feb;159(2):409-17. doi: 10.1016/j.surg.2015.07.020. Epub 2015 Aug 18.
9
Spontaneous tumor rupture and surgical prognosis of patients with hepatocellular carcinoma.肝细胞癌患者的肿瘤自发性破裂与手术预后
Scand J Gastroenterol. 2012 Sep;47(8-9):968-74. doi: 10.3109/00365521.2012.685753. Epub 2012 May 28.
10
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.

引用本文的文献

1
Prognosis and recurrence of spontaneously ruptured hepatocellular carcinoma treated after hepatectomy: A single institution experience.自发性破裂肝细胞癌行肝切除术后的预后和复发:单中心经验。
Medicine (Baltimore). 2024 Jun 14;103(24):e38555. doi: 10.1097/MD.0000000000038555.
2
Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not.BCLC A期或B期肝细胞癌出现肿瘤破裂的患者与BCLC C期未出现肿瘤破裂的患者术后生存率的比较。
Heliyon. 2024 Feb 29;10(5):e27355. doi: 10.1016/j.heliyon.2024.e27355. eCollection 2024 Mar 15.
3

本文引用的文献

1
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
2
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
3
Spontaneous ruptured hepatocellular carcinoma.自发性破裂肝细胞癌
Nomogram-based development and evaluation for predictions of 30-day and 1-year survival in patients with spontaneously ruptured hepatocellular carcinoma.
基于列线图的预测模型:用于评估自发性破裂肝细胞癌患者 30 天和 1 年生存率。
BMC Cancer. 2022 Nov 15;22(1):1177. doi: 10.1186/s12885-022-10290-3.
4
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma.针对推荐进行经动脉化疗栓塞的肝细胞癌自发性破裂患者的预后评分系统的开发。
J Gastrointest Oncol. 2022 Jun;13(3):1376-1383. doi: 10.21037/jgo-22-531.
5
Ruptured Hepatocellular Carcinoma: Current Status of Research.破裂性肝细胞癌:研究现状
Front Oncol. 2022 Feb 17;12:848903. doi: 10.3389/fonc.2022.848903. eCollection 2022.
6
Treatment strategies and prognosis for initially unresectable ruptured hepatocellular carcinoma: a single-center experience in 94 patients.初诊不可切除破裂性肝细胞癌的治疗策略和预后:94 例患者的单中心经验。
Diagn Interv Radiol. 2020 May;26(3):223-229. doi: 10.5152/dir.2019.19049.
7
Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma.经导管动脉化疗栓塞术治疗自发性破裂肝细胞癌的回顾性分析
Oncol Lett. 2019 Dec;18(6):6423-6430. doi: 10.3892/ol.2019.11037. Epub 2019 Nov 1.
8
Prognostic Factors and Survival Outcomes of Surgical Resection of Huge Hepatocellular Carcinomas.巨大肝细胞癌手术切除的预后因素及生存结果
J Gastrointest Cancer. 2020 Mar;51(1):250-253. doi: 10.1007/s12029-019-00240-x.
Hepatol Res. 2016 Jan;46(1):13-21. doi: 10.1111/hepr.12498. Epub 2015 Mar 2.
4
Partial hepatectomy for ruptured hepatocellular carcinoma.部分肝切除术治疗破裂的肝细胞癌。
Br J Surg. 2013 Jul;100(8):1071-9. doi: 10.1002/bjs.9167.
5
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey.自发性肿瘤破裂对肝细胞癌患者预后的影响:一项全国性调查的 1160 例病例分析。
Ann Surg. 2014 Mar;259(3):532-42. doi: 10.1097/SLA.0b013e31828846de.
6
Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.肝细胞癌自发破裂的预测因素和临床结局。
World J Gastroenterol. 2012 Dec 28;18(48):7302-7. doi: 10.3748/wjg.v18.i48.7302.
7
Continuous occlusion of hepatic artery proper for prevention of blood loss in partial hepatectomy for ruptured hepatocellular carcinoma: a case-matched comparative study.肝固有动脉持续阻断在预防破裂性肝细胞癌部分肝切除术中出血的应用:一项病例匹配的对照研究。
Ann Surg Oncol. 2011 Jun;18(6):1638-43. doi: 10.1245/s10434-010-1484-3. Epub 2010 Dec 22.
8
A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.一种新的可切除肝细胞癌分期系统:与中国大样本队列中 6 种现有分期系统的比较。
J Cancer Res Clin Oncol. 2011 May;137(5):739-50. doi: 10.1007/s00432-010-0935-3. Epub 2010 Jul 6.
9
Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.卡培他滨辅助治疗可延迟根治性切除术后肝细胞癌的复发:一项随机对照试验。
Ann Surg Oncol. 2010 Dec;17(12):3137-44. doi: 10.1245/s10434-010-1148-3. Epub 2010 Jul 3.
10
Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study.肝细胞癌自发性破裂肝硬化病例的生存结局及影响因素:一项多中心研究
BMC Gastroenterol. 2009 Apr 30;9:29. doi: 10.1186/1471-230X-9-29.